PATENT CLAIM ANALYSIS

Application Number: 16340666
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-07
Patent Classification: ["514", "254050"]

Abstract:
Provided are a new tubulin inhibitor and applications thereof, the tubulin inhibitor being a series of compounds based on substituted heterocyclic skeletons, targeting the colchicine binding sites of tubulin. The structure is: Formula (I), wherein: formula (A), n independently expresses an integer between 0 and 5, the condition being that n≤5, A represents mono- or poly-substituted groups, the groups being selected from the group consisting of H, C1-C20 amide group, C1-C20 acyloxy group, C1-C20 alkanoyl group, C1-C20 alkoxycarbonyl group, C1-C20 alkoxy group, C1-C20 alkylamino group, C1-C20 alkylcarboxyamino group, aroyl group, aralkanoyl group, carboxyl group, cyano group, halogen group, hydroxyl group, nitro group and methylthienyl group.

Claim (Index 4):
A pharmaceutical composition, comprising a therapeutically effective amount of the compound selected from any one of the compounds in  claim 1 .

Metadata:
- Claim Count in Document: 5.0
- Percentile: 100.0
- Lexical Diversity: 1.83562
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15579429', '10499177', '10301871', '12412837', '14711911']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7140265403675149
- 35 USC 102 Novelty (BERT): 0.546139028961052
- Combined Prediction Score: 0.6972377892268686
- Mean Citation Score: 268.43754
- Max Citation Score: 382.0325
- Similarity Product: 334.62653642341496

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test